Factors for Severe Outcomes Following Sars-Cov-2 Infection in People with Cystic Fibrosis in Europe

AuthID
P-00W-2C2
47
Author(s)
Jung, A
·
Aleksejeva, E
·
[+1]·
[+2]·
[+3]·
[+4]·
[+1]·
[+2]·
[+4]·
[+8]·
[+2]·
Zolin, A
·
Downey, DG
·
Naehrlich, L
Tipo de Documento
Article
Year published
2021
Publicado
in ERJ OPEN RESEARCH
Volume: 7, Número: 4
Indexing
Publication Identifiers
Pubmed: 34984210
SCOPUS: 2-s2.0-85123306050
Wos: WOS:000769759500039
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Jung, A;   2 Orenti, A;   3 Dunlevy, F;
4 Aleksejeva, E;   5 Bakkeheim, E;   6 Bobrovnichy, V;
7 Carr, SB;   8 Colombo, C;   9 Corvol, H;
10 Cosgriff, R;   11 Daneau, G;   12 Dogru, D;
13 Drevinek, P;   14 Vukic, AD;   15 Fajac, I;
16 Fox, A;   17 Fustik, S;   18 Gulmans, V;
19 Harutyunyan, S;   20 Hatziagorou, E;   21 Kasmi, I;
22 Kayserova, H;   23 Kondratyeva, E;   24 Krivec, U;
25 Makukh, H;   26 Malakauskas, K;   27 McKone, EF;
28 Mei Zahav, M;   29 de Monestrol, I;   30 Olesen, HV;
31 Padoan, R;   32 Parulava, T;   33 Pastor Vivero, MD;
34 Pereira, L;   35 Petrova, G;   36 Pfleger, A;
37 Pop, L;   38 van Rens, JG;   39 Rodic, M;
40 Schlesser, M;   41 Storms, V;   42 Turcu, O;
43 Wozniacki, L;   44 Yiallouros, P;   45 Zolin, A;
46 Downey, DG;   47 Naehrlich, L;